PeptiDream Inc.

Tokyo Stock Exchange 4587.T

PeptiDream Inc. Price to Book Ratio (P/B) on January 14, 2025: 6.57

PeptiDream Inc. Price to Book Ratio (P/B) is 6.57 on January 14, 2025, a 41.27% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

PeptiDream Inc. 52-week high Price to Book Ratio (P/B) is 9.60 on December 02, 2024, which is 46.14% above the current Price to Book Ratio (P/B).
PeptiDream Inc. 52-week low Price to Book Ratio (P/B) is 3.97 on February 14, 2024, which is -39.52% below the current Price to Book Ratio (P/B).
PeptiDream Inc. average Price to Book Ratio (P/B) for the last 52 weeks is 6.92.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Tokyo Stock Exchange: 4587.T

PeptiDream Inc.

CEO	Dr. Patrick Crawford Reid Ph.D.
IPO Date	June 12, 2013
Location	Japan
Headquarters	3-25-23 Tonomachi
Employees	745
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.

Key trends

Past 5 years